ASML Holding N.V. NY Registered Shares (ASML)

ASML's stock has pulled back into a downtrend after a strong year, trading at $1,534.83 and below its 50-day and 200-day moving averages ($1,667.23 and $1,601.64). The most recent report, dated October 14, 2026, beat the EPS estimate by 9.85%, yet the shares fell 3.94% in the first session afterwards. That pattern, a beat followed by a lower price, has now occurred three times in the last five reports, so investors are weighing strong results against a share price that has not kept pace with them. The stock still sits well inside its 52-week range, 56% of the way up from the low.

ASML has beaten EPS estimates in each of its last five reports. The October 14, 2026 report showed adjusted EPS of $11.82 against an estimate of $10.76, a beat of 9.85%. Despite that, the stock fell 3.94% in the first session after the report. The July 14, 2026 report also beat, by 9.06%, and the shares rose 2.87% the next session. The record shows that the stock's reaction depends on more than the headline beat, and investors appear to be pricing in expectations for the next quarter.

Net profit margin stands at 34.14% and operating margin at 44.36%, and return on equity is 65.64% against a sector median of 13.4%. Debt-to-equity is only 0.09. Those figures explain why the company earns a top health score of 5 of 5 on CleaRank's measure. The main question for the shares is whether that growth is already reflected in a valuation that is higher than most peers.

The trailing P/E ratio of 37.77, which is 7.6% above the sector median of 35.1, a level the peer benchmarking describes as broadly in line with peers. The price-to-sales ratio is 13.42 against a sector median of 7.6, a premium of 76.6%. The P/E is close to the group, but the sales multiple is far higher, which shows that the market is paying a large premium for each dollar of revenue the company generates.

The base case is that ASML continues to trade in a range while the price works back toward its short-term averages. The 20-day EMA at $1,567.37 and the 200-day SMA at $1,601.64 are the first hurdles, and a sustained move above them would be needed before the 50-day SMA at $1,667.23 comes into position. Analysts remain constructive: 38 of 41 rate the stock Buy or Strong Buy, and the median 12-month target is $2,294.35, against a range from $864.11 to $2,838.56. Analysts expect EPS to grow 67.6% this fiscal year and 36.3% next year, which is the main support for those targets. The case would weaken if the company's reported beats stop lifting the shares or if the price falls below the 200-day SMA and holds there. Lower-than-expected growth or a further break in the trend would test the nearest support levels. A simulation from past volatility is not a forecast, but the stock's typical daily move of 3.35% indicates that wide swings remain normal for this shares.

Support sits far below the price. The nearest level below the price is the 52-week low at $946.11, so a fall would meet that level first. Resistance is layered above. The nearest level above is the 20-day EMA at $1,567.37, followed by the 200-day SMA at $1,601.64, the 50-day SMA at $1,667.23, and the 52-week high at $1,999.96. The first two resistance levels sit close to the price, and a move through them would be the first sign that the downtrend is weakening.